A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)

NCT00735267 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
468
Enrollment
INDUSTRY
Sponsor class

Stopped Please see Detailed Description for termination reason.

Conditions

Interventions

Sponsor

Pfizer